Brain Cancer | Tumor

‘Chicago Med’ Actress Reveals Cancer Diagnosis, Phillies Dollar Hot Dog Night Leads to a Cancer Diagnosis and More

September 30th 2022

From “Chicago Med” actress Marlyne Barrett announcing her gynecologic cancer diagnosis to a New York City-based news team walking in honor of their former news director who died of glioblastoma, a form of brain and spinal cord cancer, here’s what’s happening in the cancer space this week.

Some Health Appointments Will Be Delayed for Queen Elizabeth II’s Funeral, Ryan Reynolds Gets Colonoscopy and Has Potentially Pre-Cancerous Polyp Removed and More

September 16th 2022

From the delay of some health care services in the United Kingdom due to Queen Elizabeth II’s funeral to actor Ryan Reynolds broadcasting his colonoscopy — including the finding of a pre-cancerous polyp — here’s what’s happening in the cancer space this week.

My Insights to Cancer Genetics After More Than 20 Years of Brain Tumor Survival

July 28th 2022

After being a 20-year brain tumor survivor, I met with a genetic counselor and learned that I have a MUYTH gene mutation.

FDA Fast Tracks Investigational Drug for the Treatment of Recurrent Brain Cancer

July 15th 2022

The safety, optimal dosage and efficacy of the investigational drug is currently being evaluated in a first-in-human trial in patients with recurrent high-grade glioblastoma, a type of spinal cord and brain cancer.

Patient Receives Treatment With Novel Drug in First-in-Human Trial Assessing its Safety and Efficacy in Brain and Lung Cancer

April 25th 2022

The drug, known as BDTX-1535, is being investigated in patients with glioblastoma that harbors EGFR alterations and non-small cell lung cancer that harbors EGFR mutations of intrinsic or acquired resistance and disease that has failed standard treatment.

Early-Phase Trial to Investigate Novel CAR-T Cell Therapy Alongside Oncolytic Virus in Recurrent Brain Cancer Set to Launch

April 18th 2022

The plan to launch the phase 1 trial to evaluate the safety and efficacy of combining the CAR-T cell therapy and oncolytic virus in patients with recurrent glioblastoma, a type of brain cancer, is supported by interim data from two ongoing trials.

Clinical Trial Investigating a Combo Therapy in Brain Cancer Now Enrolling Patients

March 28th 2022

The study authors plan to enroll 24 patients with glioblastoma, an aggressive brain tumor, to assess the efficacy an investigational drug plus Libtayo prior to surgery to remove the tumor.

Trial for Brain Cancer Immunotherapy Treatment Opens

February 7th 2022

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

I’m Not a Cancer Warrior or Fighter, I’m a ‘Traveler’

February 2nd 2022

A brain cancer survivor explains how she found a way to navigate her cancer journey as a traveler, grateful to be alive.

Living With Uncertainty as a Brain Tumor Survivor in a Changing World

January 16th 2022

A brain tumor survivor explains how she chooses to approach life with acceptance of the hard times rather than trying to throw them away.

Survival With Immunotherapy in Common Brain Tumor Subtype May Be Predicted by a Biomarker

January 3rd 2022

Patients with a common brain tumor subtype that expresses ERK1/2 activation may obtain a greater survival benefit with PD-1 immunotherapy, although research needs to confirm whether this can be observed in all patients.

Top 5 Brain Cancer News Stories of 2021

December 29th 2021

From celebrity deaths to exciting new treatments, here is CURE®’s roundup of what made waves in the brain cancer space this year.

President Biden Acknowledges 50th Anniversary of National Cancer Act, Proposes Launching New Agency to Expedite Cancer Breakthroughs

December 23rd 2021

Upon recognizing the 50th anniversary of the National Cancer Act of 1971, President Joe Biden set forth his proposal for the Advanced Research Projects Agency for Health.

Atlanta Anchor Jovita Moore Dies From Cancer, Journalist Boyd Huppert Shares Diagnosis and More

November 5th 2021

From the deaths of Jovita Moore and Jerry Remy due to cancer, to Boyd Huppert’s myeloma diagnosis, here’s what’s happening in the cancer landscape this week.

Cancer Type May Help Predict Where Brain Metastases Will Occur

October 27th 2021

When a patient’s cancer spreads to the brain, their original cancer type may predict what region of the brain the metastasis occurs in, according to new findings. The research could lead to better treatment approaches in the future.

Cancer Researchers Are Expanding Options for Brain Metastases

October 14th 2021

Brain metastases are a pattern of spread we are seeing more for many tumor types as patients are living longer with metastatic cancer and we more readily use an array of brain imaging technologies when needed.

FDA Approves Welireg for Several Cancers Associated With VHL Disease

August 13th 2021

The FDA granted approval to Welireg for the treatment of patients with von Hippel-Lindau-associated kidney cancer, CNS hemangioblastomas and pancreatic neuroendocrine tumors.

Vaccine May Improve Survival Outcome in Patients with Newly Diagnosed Brain Cancer

June 14th 2021

The vaccine significantly improved a survival outcome over standard-of-care treatment in patients with newly diagnosed glioblastoma.

Brain Cancer Interrupted My Life at the Peak of My Career

May 14th 2021

A long-term brain cancer survivor shares the story of his cancer journey and where it led his life.

The Latest Updates in the Field of Brain Cancer Research

May 14th 2021

In honor of Brain Cancer Awareness Month, CURE® spoke with an expert about the latest advances that researchers are working on for patients with this disease.

Children’s Hospital L.A. Unveils Mural of Chadwick Boseman, Apollo 11 Astronaut Michael Collins Dies from Cancer, And More

April 30th 2021

From a mural of Chadwick Boseman in a Los Angeles children’s hospital to the death of Apollo 11 astronaut Michael Collins, here’s what’s happening in the cancer landscape this week.

5-Year-Old Celebrates His Final Round of Radiation at A Boston Bruins Game, Exodus Drummer Tom Hunting Announces Cancer Diagnosis, and More

April 16th 2021

From a 5-year-old with brain cancer celebrating his final round of radiation at a hockey game to a cancer diagnosis for Exodus drummer Tom Hunting, here’s what’s happening in the cancer landscape this week.

FDA Recommends Early Conclusion Following Positive Results of Phase 2 Trial Assessing Novel Therapy in GBM

April 16th 2021

The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.

Improving Outcomes for Patients With Brain Metastases

March 15th 2021

A Caregiver’s Perspective on Treatment Success

March 15th 2021

Feeling Supported During the Diagnosis and Treatment of Brain Metastases

March 15th 2021

Effect of Brain Metastasis Treatment on Quality of Life

March 8th 2021

Individual Assessment of Treatment Success With Brain Metastases

March 8th 2021

Personal Concerns With Treatment Options for Brain Metastases

March 1st 2021

Importance of Clinical Trial Enrollment for Patients With Brain Metastases

March 1st 2021